AGM
RNAM

Alpine Global Management’s Avidity Biosciences RNAM Stock Holding History

Alpine Global Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$500 – 391
2025
Q4 		$500 Buy
+200
New +$12.9K ﹤0.01% 343

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Alpine Global Management's RNAM Position: Q1 2026 in Review

Alpine Global Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 40,000 shares — an estimated $2.89M sold.

Alpine Global Management first reported a position in RNAM in Q2 2024 and held it in 2 quarters. The position peaked at $2.89M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Alpine Global Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Alpine Global Management sold 40,000 Avidity Biosciences shares in Q1 2026, an estimated $2.89M.
  • Alpine Global Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 2 quarters.
  • Alpine Global Management's Avidity Biosciences position peaked at $2.89M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.